First Manhattan’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2022
Q4 | – | Sell |
-60
| Closed | -$5K | – | 1697 |
|
2022
Q3 | $5K | Hold |
60
| – | – | ﹤0.01% | 1302 |
|
2022
Q2 | $4K | Hold |
60
| – | – | ﹤0.01% | 1355 |
|
2022
Q1 | $4K | Hold |
60
| – | – | ﹤0.01% | 1405 |
|
2021
Q4 | $5K | Hold |
60
| – | – | ﹤0.01% | 1368 |
|
2021
Q3 | $4K | Hold |
60
| – | – | ﹤0.01% | 1418 |
|
2021
Q2 | $5K | Hold |
60
| – | – | ﹤0.01% | 1381 |
|
2021
Q1 | $4K | Buy |
+60
| New | +$4K | ﹤0.01% | 1366 |
|
2019
Q2 | – | Sell |
-600
| Closed | -$53K | – | 1367 |
|
2019
Q1 | $53K | Hold |
600
| – | – | ﹤0.01% | 944 |
|
2018
Q4 | $51K | Hold |
600
| – | – | ﹤0.01% | 921 |
|
2018
Q3 | $58K | Hold |
600
| – | – | ﹤0.01% | 951 |
|
2018
Q2 | $56K | Hold |
600
| – | – | ﹤0.01% | 933 |
|
2018
Q1 | $48K | Sell |
600
-625
| -51% | -$50K | ﹤0.01% | 961 |
|
2017
Q4 | $109K | Buy |
1,225
+625
| +104% | +$55.6K | ﹤0.01% | 829 |
|
2017
Q3 | $55K | Buy |
+600
| New | +$55K | ﹤0.01% | 931 |
|